Please login to the form below
pricing
This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.
Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities
The 12 key goals on Act4Biosimilars.com have been identified by the Steering Committee using the ‘4As’ criteria, which include: ensuring equitable pricing, involving patients in treatment decisions and streamlining biosimilar
Latest news
-
UICC launches global ATOM Coalition to increase access to essential cancer medicines
As one of the Coalition partners, AstraZeneca’s global vice president of oncology market access and pricing, Beth Hamilton, said: “A critical component of reducing cancer mortality is improving equity in
-
EFPIA pledges to boost drug access throughout Europe
Provided that local systems allow it, EFPIA firms are now committed to file for pricing and reimbursement in all EU countries as soon as possible – no later than two years from ... The time between getting marketing authorisation and companies filing
-
Pfizer agrees to supply UNICEF with up to 4 million courses of oral COVID-19 treatments
price detailed in Pfizer’s tiered pricing guidelines.
-
bluebird bio’s beti-cel accepted for priority review by FDA
In Germany, the only country where the pricing details are known, the authorities offered to pay $790, 000 per patient, rising to $950, 000 after five years if the therapy is
-
US government to pay $5.3bn for Pfizer‘s Paxlovid
Pfizer has also entered into advance purchase agreements with several other countries, as well as committing to “equitable access” at an affordable price for poorer countries through a tiered pricing approach
More from news
Approximately 109 fully matching, plus 912 partially matching documents found.
Latest Intelligence
-
Health technology assessments: understanding the global landscape and considerations for drug development
Accordingly, companies are broadening their early health economics and outcomes research (HEOR), pricing and market access research initiatives and investment on a global scale. ... This list of country-level nuances only scratches the surface. Still, it
-
Communicating for change – creating effective medical communications
to support initial pricing and market access considerations for forecasting, product value, positioning options and patient segmentation?
-
Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
efficacy, safety, pricing, medicine administration). Test messaging and language. o Engage and learn from the online community (without mentioning your product).
-
Piloting a route to the biosimilars opportunities in Europe
The increased competition also forces originator/biologic manufacturers and sellers to reduce the pricing of their innovative products, further adding to the affordability of important treatments. ... and. lead to supply shortages), to fixed
-
Product launches: making the most of your one shot
So why does it go wrong so often? There are many potential reasons, including a lack of engagement with key medical and payer stakeholders, an inadequate pricing and market access strategy
More from intelligence
Approximately 16 fully matching, plus 197 partially matching documents found.
Latest appointments
-
New faces at Lucid Group and ZPB Associates
Most recently, she worked in the consultancy’s rare diseases division, where is provided crisis management support in pricing/access barriers for an orphan drug.
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
Both O’Leary and Massey have experience of delivering evidence-based pricing and market access communications to help build global brands.
-
New faces at GCI Health, Porterhouse Medical and Research Partnership
Meanwhile Emma Warburton joins the agency as business development executive after previously working as a pricing and market research analyst.
-
BMS appoints new commercial leader, Davies joins Eisai and more
She will also oversee marketing, pricing, forecasting and analytics. Brian Hoffmann, president of Hikma’s generics division, said: “I am looking forward to working closely with Kristy and her team to
-
Weekly comms appointments
Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and
More from appointments
Approximately 2 fully matching, plus 31 partially matching documents found.
Latest from PMHub
-
Innovative contracting at the top of the market access agenda
Pharma and biotech, patients, payers, regulators and HTA agencies gathered at the World Evidence, Pricing and Access Congress in March to discuss challenges and potential solutions. ... Pharma and biotech, patients, payers, regulators and HTA agencies
-
Nucleus X Consulting – where patient engagement meets strategic consultancy
Challenges associated with a rare disease product launch. Launching a product in a rare disease is becoming progressively challenging, with increased competition and pricing pressures, regulators demanding more evidence of therapeutic
-
Nucleus Global launches Nucleus X Consulting, a specialist consultancy with deep expertise in patient engagement, rare disease, and early-phase medical commercialization
Product launches are becoming progressively more challenging, with increased competition and pricing pressures, regulators demanding more evidence of therapeutic value, and patients driving treatment decisions and impacting on success through
-
Accelerating HTA and payer submissions: how digital connectivity is driving faster patient access
Develop innovative pricing and contracting models that resonate with local stakeholder needs. Manage limited time and resources.
-
Robust Review: Pricing & Market Access
See how our client utilized Rapid Payer Response (RPR) to gain invaluable Payer insight into the Pricing and Market Access acceptability of their novel product within 3 Weeks. ... Robust Review: Pricing &Market Access.
More from PMHub
Approximately 6 fully matching, plus 73 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Moderna to launch Innovation and Technology Center in the UK
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- VMLY&R wins two Grand Prix awards at Cannes Lions International Festival of Creativity 2022
- How digital health is changing the relationship between patients and health providers | OPEN Health
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Roche shares new positive Ocrevus data for MS patients
- Six UK universities receive grant for research into motor neurone disease
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
